Since GPR56 expression in LSCs is significantly higher than that in HSCs9,15 and downregulation of GPR56 induces apoptosis of EVI1high AML cells, GPR56 may serve as a potential molecular therapeutic target for EVI1high AML. This evidence concerns the gene ADGRG1 and acute myeloid leukemia.